Elivra Jimenez-Schreck – Trademark Portfolio

Entity Type: 01

Elivra Jimenez-Schreck holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VIDA. The owner is based in Chicago, IL.

3000 S. Throop St.

Chicago, IL 60608

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VIDA
VIDA
Registered 2017
VIDA
VIDA
Registered 2017

Trademark Classifications

Elivra Jimenez-Schreck's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Elivra Jimenez-Schreck have?

Elivra Jimenez-Schreck has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Elivra Jimenez-Schreck file in?

Elivra Jimenez-Schreck files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 41 (Education & Entertainment). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Elivra Jimenez-Schreck's most well-known trademarks?

Elivra Jimenez-Schreck's registered trademark portfolio includes well-known marks such as VIDA. These are among 2 currently registered trademarks in the portfolio.

What is Elivra Jimenez-Schreck's trademark registration success rate?

Elivra Jimenez-Schreck has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.